2seventy bio, Inc. provided revenue guidance for the year of 2022. For the year, the company expected revenue to be in the range of $250 million - $300 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.8 USD | -4.00% | +9.59% | +12.41% |
08/05 | Earnings Flash (TSVT) 2SEVENTY BIO Reports Q1 Revenue $12.4M, vs. Street Est of $14.1M | MT |
08/05 | Transcript : 2seventy bio, Inc., Q1 2024 Earnings Call, May 08, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.41% | 25Cr | |
+33.63% | 5.09TCr | |
-0.09% | 4.21TCr | |
+49.62% | 4.2TCr | |
-4.96% | 2.92TCr | |
+11.18% | 2.6TCr | |
-21.95% | 1.89TCr | |
+8.61% | 1.32TCr | |
+24.73% | 1.22TCr | |
+28.31% | 1.22TCr |
- Stock Market
- Equities
- TSVT Stock
- News 2seventy bio, Inc.
- 2seventy Bio, Inc. Provides Revenue Guidance for the Year of 2022